PPARA and Parkinson disease: Another particularly important issue in pharmacological research is the fact that the majority of in vivo studies, in general, employ male experimental animals, and, therefore, comprehensive knowledge about the effectiveness of PPARα agonists on AD and PD pathology in females is lacking.